# Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer

> **NCT03367572** · PHASE3 · COMPLETED · sponsor: **University of Rochester NCORP Research Base** · enrollment: 1363 (actual)

## Conditions studied

- Breast Carcinoma

## Interventions

- **DRUG:** Dexamethasone
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Netupitant/Palonosetron Hydrochloride
- **DRUG:** Olanzapine
- **OTHER:** Placebo
- **DRUG:** Prochlorperazine
- **OTHER:** Quality-of-Life Assessment

## Key facts

- **NCT ID:** NCT03367572
- **Lead sponsor:** University of Rochester NCORP Research Base
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-19
- **Primary completion:** 2024-04-13
- **Final completion:** 2024-04-13
- **Target enrollment:** 1363 (ACTUAL)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03367572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03367572, "Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03367572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*